NIH Grants & Funding /
Participating Organization: National Institute of Neurological Disorders and Stroke (NINDS)
| FOA Number | Co-Funders | Title | Clinical Trial | Activity Code | Application Due Date |
|---|---|---|---|---|---|
| RFA-NS-22-034 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Cancer Institute (NCI), National Center for Advancing Translational Sciences (NCATS), National Center for Complementary and Integrative Health (NCCIH), National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Aging (NIA), National Institute on Alcohol Abuse and Alcoholism (NIAAA) | HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment | Not allowed | R01 | ClosedMarch 02, 2022 to October 02, 2024 |
| PAR-22-055 | National Institute of Neurological Disorders and Stroke (NINDS) | Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets | Not allowed | R61/R33 | ClosedMarch 15, 2022; March 14, 2023; and March 14, 2024 |
| PAR-21-122 | National Institute of Neurological Disorders and Stroke (NINDS) | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies | Not allowed | R61/R33 | ClosedOctober 19, 2021 to February 20, 2024 |
| PAR-21-123 | National Institute of Neurological Disorders and Stroke (NINDS) | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery | Not allowed | R61/R33 | ClosedOctober 19, 2021 to February 20, 2024 |
| PAR-21-124 | National Institute of Neurological Disorders and Stroke (NINDS) | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification | Not allowed | R61/R33 | ClosedOctober 19, 2021 to February 20, 2024 |